| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/14/2005 | CA2814613A1 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 04/14/2005 | CA2776997A1 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/14/2005 | CA2542004A1 Chimeric carrier molecules for the production of mucosal vaccines |
| 04/14/2005 | CA2542002A1 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis |
| 04/14/2005 | CA2541823A1 Hypoxia responsive human cngh 0002 genes and polypeptides |
| 04/14/2005 | CA2541240A1 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/14/2005 | CA2541015A1 Igf binding proteins |
| 04/14/2005 | CA2541006A1 Tim-3 polypeptides |
| 04/14/2005 | CA2540875A1 Compositions and processes for genotyping single nucleotide polymorphisms |
| 04/14/2005 | CA2540857A1 Gene modulation by rb2/p130 expression |
| 04/14/2005 | CA2540854A1 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 04/14/2005 | CA2540837A1 Mammalian t1r3 sweet taste receptors |
| 04/14/2005 | CA2540667A1 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 04/14/2005 | CA2540665A1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 04/14/2005 | CA2540622A1 Transgenic animals with serious disorders related to alzheimer's disease |
| 04/14/2005 | CA2540520A1 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain |
| 04/14/2005 | CA2540348A1 Methods for enhancing stress tolerance in plants and methods thereof |
| 04/14/2005 | CA2540253A1 Hiv-dependent expression constructs and uses therefor |
| 04/14/2005 | CA2540244A1 Methods and compositions for defining gene function |
| 04/14/2005 | CA2538918A1 Process for producing intermediate of useful alkaloid biosynthesis according to rnai method |
| 04/14/2005 | CA2537793A1 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 04/14/2005 | CA2537492A1 Secretion of proteins from yeasts |
| 04/14/2005 | CA2537326A1 C1q related protein |
| 04/14/2005 | CA2533116A1 Apparatus for generating electrical pulses and methods of using the same |
| 04/14/2005 | CA2526690A1 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors |
| 04/14/2005 | CA2515583A1 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 04/13/2005 | EP1522597A1 Nucleic acid amplification method |
| 04/13/2005 | EP1522591A2 Transgenically produced non-secreted proteins |
| 04/13/2005 | EP1522590A1 Methods for producing modified glycoproteins |
| 04/13/2005 | EP1522588A2 Accessory functions for use in recombinant AAV virion production |
| 04/13/2005 | EP1522587A2 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electric current |
| 04/13/2005 | EP1522585A1 Chimeric carrier molecules for the production of mucosal vaccines |
| 04/13/2005 | EP1522584A2 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 04/13/2005 | EP1522583A2 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sina) |
| 04/13/2005 | EP1522582A2 Optical sorting method |
| 04/13/2005 | EP1522581A2 Optical sortingmethod |
| 04/13/2005 | EP1522579A2 Hyaluronan synthase gene and uses thereof |
| 04/13/2005 | EP1522578A1 Transferring materials into cells using porous silicon |
| 04/13/2005 | EP1522039A2 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 04/13/2005 | EP1521963A2 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby |
| 04/13/2005 | EP1521849A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/13/2005 | EP1521847A2 Marker genes for determining renal toxicity |
| 04/13/2005 | EP1521846A2 Serrs reactive particles |
| 04/13/2005 | EP1521845A1 Method for detecting increased susceptibility to tumours |
| 04/13/2005 | EP1521840A1 Electroporation method including the use of depressurization/pressurization |
| 04/13/2005 | EP1521839A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 04/13/2005 | EP1521838A1 Method for modifying plants |
| 04/13/2005 | EP1521837A2 Plasmid vectors for transformation of filamentous fungi |
| 04/13/2005 | EP1521836A2 Novel acetylcholinesterase gene responsible for insecticide resistance and applications thereof |
| 04/13/2005 | EP1521835A1 Use of ahas mutant genes as selection marker in potato transformation |
| 04/13/2005 | EP1521834A1 Use of a gene for increasing the oil content in plants |
| 04/13/2005 | EP1521833A2 Synthetic herbicide resistance gene |
| 04/13/2005 | EP1521832A2 Genes |
| 04/13/2005 | EP1521831A2 Transgenic animal expressing alzheimer's tau protein |
| 04/13/2005 | EP1521830A2 Tcf / beta-catenin regulated genes for treating cancer |
| 04/13/2005 | EP1521829A2 Target dna |
| 04/13/2005 | EP1521828A2 Production of polyketides |
| 04/13/2005 | EP1521827A1 Modulation of cytochrome p450 reductase activity |
| 04/13/2005 | EP1521826A1 A simple, efficient, and accelerated method for enzyme-catalyzed in vitro modification and synthesis of nucleic acid using microwave irradiation |
| 04/13/2005 | EP1521825A2 Pin1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521776A2 Neoplasm specific antibodies and uses thereof |
| 04/13/2005 | EP1521775A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
| 04/13/2005 | EP1521774A2 Truncated tau proteins |
| 04/13/2005 | EP1521772A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 04/13/2005 | EP1521771A1 STREPTOCOCCUS PNEUMONIAE PBP2x MINI-PROTEIN AND USES THEREOF. |
| 04/13/2005 | EP1521770A1 Method for the production of protamine |
| 04/13/2005 | EP1521768A2 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/13/2005 | EP1521767A2 Methods and constructs for high yield expression of clostripain |
| 04/13/2005 | EP1521766A2 SPLICEOSOME MEDIATED RNA i TRANS /i -SPLICING AND CORRECTION OF FACTOR VIII GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLING |
| 04/13/2005 | EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 04/13/2005 | EP1521594A2 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 04/13/2005 | EP1521585A1 Immunostimulation by chemically modified rna |
| 04/13/2005 | EP1521520A2 Methods for developing animal models |
| 04/13/2005 | EP1487261A4 Methods and compositions for pharmacological and toxicological evaluation of test agents |
| 04/13/2005 | EP1465912A4 Novel chimeric tnf ligands |
| 04/13/2005 | EP1463749A4 Novel human kinases and polynucleotides encoding the same |
| 04/13/2005 | EP1453973A4 Methods for determining transcriptional activity |
| 04/13/2005 | EP1438425A4 69583 and 85924,novel human protein kinase family members and uses therefor |
| 04/13/2005 | EP1436379A4 Dna fpr expression of alpha i-antitrypsin in methylotropic yeast |
| 04/13/2005 | EP1414840A4 Genomics applications for modified oligonucleotides |
| 04/13/2005 | EP1356075A4 Protein scaffolds for antibody mimics and other binding proteins |
| 04/13/2005 | EP1317484B1 Variants of the phleum pratense phl p 1 allergenic protein |
| 04/13/2005 | EP1229782A4 Pathogen tolerance genes |
| 04/13/2005 | EP1210441B1 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/13/2005 | EP1180153B1 Phage-dependent super-production of biologically active proteins and peptides |
| 04/13/2005 | EP1090143B1 Method for quantifying tgf-beta |
| 04/13/2005 | EP1082454A4 Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy |
| 04/13/2005 | EP1074624B1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene |
| 04/13/2005 | EP1023312A4 Method for modulating gene expression |
| 04/13/2005 | EP1015469B1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 04/13/2005 | EP1012250A4 Regulation of gene expression in plants |
| 04/13/2005 | EP0956052B1 Chimeric retrovirus/adenovirus system |
| 04/13/2005 | EP0938555B1 Constructs and complexes of cyclin e |
| 04/13/2005 | EP0930893B1 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/13/2005 | EP0915897B1 Process for combining parallel oligonucleotide synthesis and preparation of oligomer chips |
| 04/13/2005 | EP0871737B1 Method of protecting crop plants against insect pests |
| 04/13/2005 | EP0857217B1 Novel expression vectors and methods of use |